Korea Joongang Daily on MSN4h
Celltrion's Actemra biosimilar gets FDA approval
Celltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.
Zacks.com on MSN17h
Roche's 2024 Sales and Earnings Beat, Key Drugs Perform WellSwiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback